Do Patients need Lifelong β-Blockers after an Uncomplicated Myocardial Infarction?

‘Ten commandments’ for the 2018 ESC/EACTS Guidelines on Myocardial Revascularization

(2019) Franz-Josef Neumann et al.   EUROPEAN HEART JOURNAL

Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry

(2018) Fabrizio D’Ascenzo et al.   American Journal of Cardiovascular Drugs

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2017) Borja Ibanez et al.   EUROPEAN HEART JOURNAL

β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction

(2017) Tatendashe B. Dondo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study

(2016) Etienne Puymirat et al.   BMJ-British Medical Journal

β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study

(2016) Etienne Puymirat et al.   BMJ-British Medical Journal

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

(2015) Marco Roffi et al.   EUROPEAN HEART JOURNAL

Clinical Outcomes with β-Blockers for Myocardial Infarction: A Meta-analysis of Randomized Trials

(2014) Sripal Bangalore et al.   AMERICAN JOURNAL OF MEDICINE

Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure

(2013) Kim Fox et al.   AMERICAN HEART JOURNAL

Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention

(2013) Borja Ibanez et al.   CIRCULATION

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary

(2012) Patrick T. O’Gara et al.   CIRCULATION

β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease

(2012) Sripal Bangalore et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update

(2011) Sidney C. Smith et al.   CIRCULATION

Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling

(2011) Jillian G. Baker et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Beta-Blockers in Hypertension

(2010) C. Venkata S. Ram   AMERICAN JOURNAL OF CARDIOLOGY

Heart rate management in coronary artery disease: the CLARIFY registry

(2009) P. G. Steg   EUROPEAN HEART JOURNAL SUPPLEMENTS

Verapamil-sustained release–based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: An INternational VErapamil SR-Trandolapril (INVEST) substudy

(2008) Sripal Bangalore et al.   AMERICAN HEART JOURNAL

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

(2008) Kim Fox et al.   LANCET